Serial Number 88981401
Registration 6382036
700

Registration Progress

Application Filed
Jul 30, 2018
Under Examination
Feb 19, 2019
Approved for Publication
Dec 25, 2018
Published for Opposition
Dec 25, 2018
Registered
Jun 8, 2021

Trademark Image

Basic Information

Serial Number
88981401
Registration Number
6382036
Filing Date
July 30, 2018
Registration Date
June 8, 2021
Published for Opposition
December 25, 2018
Drawing Code
2

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 8, 2021
Registration
Registered
Classes
005

Rights Holder

Calithera Biosciences, Inc.

03
Address
343 Oyster Point Blvd, Suite 200
South San Francisco, CA 94080

Ownership History

Calithera Biosciences, Inc.

Original Applicant
03
South San Francisco, CA

Calithera Biosciences, Inc.

Owner at Publication
03
South San Francisco, CA

Calithera Biosciences, Inc.

Original Registrant
03
South San Francisco, CA

Legal Representation

Attorney
Jenevieve Maerker

USPTO Deadlines

Next Deadline
678 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-06-08)
Due Date
June 08, 2027
Grace Period Ends
December 08, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

32 events
Date Code Type Description Documents
Jun 8, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
May 4, 2021 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
May 2, 2021 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Apr 24, 2021 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Apr 23, 2021 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Apr 23, 2021 DPCC D DIVISIONAL PROCESSING COMPLETE Loading...
Mar 8, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Feb 18, 2021 DRRR I DIVISIONAL REQUEST RECEIVED Loading...
Feb 18, 2021 IUAF S USE AMENDMENT FILED Loading...
Feb 18, 2021 ERTD I TEAS REQUEST TO DIVIDE RECEIVED Loading...
Feb 18, 2021 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Aug 21, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 19, 2020 EX3G S SOU EXTENSION 3 GRANTED Loading...
Aug 19, 2020 EXT3 S SOU EXTENSION 3 FILED Loading...
Aug 19, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 29, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 19, 2020 EX2G S SOU EXTENSION 2 GRANTED Loading...
Feb 19, 2020 EXT2 S SOU EXTENSION 2 FILED Loading...
Feb 19, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 10, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 8, 2019 EX1G S SOU EXTENSION 1 GRANTED Loading...
Aug 8, 2019 EXT1 S SOU EXTENSION 1 FILED Loading...
Aug 8, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 19, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Dec 25, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 25, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 5, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 16, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 15, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 4, 2018 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Aug 3, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 2, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
House mark for pharmaceuticals for the treatment of cystic fibrosis; house mark for pharmaceuticals for the treatment of genetic diseases and disorders
First Use Anywhere: Jun 23, 2020
First Use in Commerce: Jun 23, 2020

Additional Information

Design Mark
The mark consists of a trefoil shape formed by three interlocking arcs, with one corner of each arc meeting to form a dot in the center of the design.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005